PANCREATIC SOCIETY OF GREAT BRITAIN AND IRELAND
To promote and encourage, for the benefit of the public, the study of and research into diseases of the pancreas and to disseminate knowledge and hold discussions on the results of such study and research.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds increased to £270,487, exceeding the trustees' stated reserves policy target of £20,000. The charity reported a net surplus of £20,470 for the year, with total income of £81,645 against charitable expenditure of £61,175. The trustees confirmed there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“The trustees have implemented a policy that reserves are not to fall below £20,000.” — page 4
Register events
- Received assets from another charity (18/01/2024)
Trustees
- Dr John Leeds
- Professor Christopher Halloran
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £82k | £61k |
| 30/06/2024 | £113k | £90k |
| 30/06/2023 | £146k | £75k |
| 30/06/2022 | £35k | £39k |
| 30/06/2021 | £9k | £30k |
Common questions
Is PANCREATIC SOCIETY OF GREAT BRITAIN AND IRELAND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds increased to £270,487, exceeding the trustees' stated reserves policy target of £20,000. The charity reported a net surplus of £20,470 for the year, with total income of £81,645 against charitable expenditure of £61,175. The trustees confirmed there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.